EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Silico and In Vitro Studies on Selective MAO-B Inhibition and Predicted Microbiome Interactions of Novel Chalcone Derivatives: Relevance to the Gut–Brain Axis in Autism Spectrum Disorder

Duaa A. Aqeel, Haneen A. Al-Mazroua, Nawaf A. Alsaif, Hatun A. Alomar, Ahmed H. Bakheit, Faizah A. Binjubair, Huda S. Al-Salem

Pharmaceuticals · 18.11.2026 · 19 (11) · 1839

DOI: 10.3390/ph19111839 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 18.11.2026. Verfasst von Duaa A. Aqeel und 6 weiteren Autor:innen. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Autism spectrum disorder (ASD) lacks pharmacological therapies for its core features. This study synthesized chalcone derivatives, determined their monoamine oxidase A (MAO-A) and MAO-B inhibitory profiles, and generated computational hypotheses regarding MAO-B binding, gut–bacterial protein interactions, and drug-like properties.

Methods

Sixteen chalcones (23–38; fifteen newly reported) were synthesized and characterized. MAO-A and MAO-B inhibition was measured using fluorometric concentration–response assays, with clorgyline and safinamide as references. Compounds 23, 26, 35, and 37 were docked against human MAO-B (PDB 2V5Z), Bacteroides fragilis profragilysin-3 (PDB 7POU), and Lacticaseibacillus casei thymidylate synthase (PDB 1LCA and 3IK1), and subjected to in silico ADMET assessment.

Results

Compound 37 showed the best balance of MAO-B potency and selectivity, with an IC50 of 0.636 µM and a selectivity index of 16.65. Compound 35 was also MAO-B-selective (IC50 = 2.52 µM; selectivity index = 13.24). Compound 34 was the most potent dual inhibitor (MAO-A IC50 = 0.647 µM; MAO-B IC50 = 0.272 µM), whereas none met the predefined MAO-A-selectivity threshold. Docking suggested accommodation of the chalcones within the MAO-B cavity, the peripheral hesperetin-binding pocket of profragilysin-3, and the thymidylate-synthase folate/dUMP cleft. Predicted ADMET profiles indicated limited absorption, extensive protein binding, and potential hepatic and genotoxic liabilities.

Conclusions

Compound 37 is the leading selective MAO-B scaffold, while compound 35 provides a second selective chemotype. The bacterial-target docking and ADMET findings are hypothesis-generating only and do not demonstrate effects on toxin activity, bacterial growth, microbiome composition, safety, central exposure, or ASD-related outcomes. Enzyme kinetics, target-engagement, permeability, genotoxicity, and microbiological studies are required before in vivo evaluation.

Förderung

  • King Saud University

Zitieren

APA

Aqeel, D. A., Al-Mazroua, H. A., Alsaif, N. A., Alomar, H. A., Bakheit, A. H., Binjubair, F. A., & Al-Salem, H. S. (2026). In Silico and In Vitro Studies on Selective MAO-B Inhibition and Predicted Microbiome Interactions of Novel Chalcone Derivatives: Relevance to the Gut–Brain Axis in Autism Spectrum Disorder. Pharmaceuticals, 19(11), 1839. https://doi.org/10.3390/ph19111839

Vancouver

Aqeel DA, Al-Mazroua HA, Alsaif NA, Alomar HA, Bakheit AH, Binjubair FA, et al. In Silico and In Vitro Studies on Selective MAO-B Inhibition and Predicted Microbiome Interactions of Novel Chalcone Derivatives: Relevance to the Gut–Brain Axis in Autism Spectrum Disorder. Pharmaceuticals. 2026;19(11):1839. doi:10.3390/ph19111839

BibTeX
@article{Aqeel2026,
  author = {Aqeel, Duaa A. and Al-Mazroua, Haneen A. and Alsaif, Nawaf A. and Alomar, Hatun A. and Bakheit, Ahmed H. and Binjubair, Faizah A. and Al-Salem, Huda S.},
  title = {In Silico and In Vitro Studies on Selective MAO-B Inhibition and Predicted Microbiome Interactions of Novel Chalcone Derivatives: Relevance to the Gut–Brain Axis in Autism Spectrum Disorder},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {11},
  pages = {1839},
  doi = {10.3390/ph19111839}
}
Kostenlos starten →